121 related articles for article (PubMed ID: 1835198)
1. Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure.
Perico N; Pasini M; Gaspari F; Abbate M; Remuzzi G
Transplantation; 1991 Nov; 52(5):873-8. PubMed ID: 1835198
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft.
Perico N; Rossini M; Imberti O; Malanchini B; Cornejo RP; Gaspari F; Bertani T; Remuzzi G
J Am Soc Nephrol; 1992 Mar; 2(9):1398-404. PubMed ID: 1385733
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.
Spurney RF; Fan PY; Ruiz P; Sanfilippo F; Pisetsky DS; Coffman TM
Kidney Int; 1992 Apr; 41(4):973-82. PubMed ID: 1387435
[TBL] [Abstract][Full Text] [Related]
5. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure.
Badr KF; Kelley VE; Rennke HG; Brenner BM
Kidney Int; 1986 Oct; 30(4):474-80. PubMed ID: 3537451
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs.
Ito BR; Roth DM; Engler RL
Circ Res; 1990 Mar; 66(3):596-607. PubMed ID: 2137727
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation.
Rossini M; Belloni A; Remuzzi G; Perico N
Circulation; 1990 Jan; 81(1 Suppl):I61-7; discussion I68. PubMed ID: 2136819
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.
Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
Stork JE; Dunn MJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
dos Santos OF; Boim MA; Barros EJ; Pirotzky E; Braquet P; Schor N
Lipids; 1991 Dec; 26(12):1320-3. PubMed ID: 1819724
[TBL] [Abstract][Full Text] [Related]
11. Protection of glomerular filtration rate by the thromboxane receptor antagonist L655,240 during low dose cyclosporine administration.
Bunke M; Wilder L; Martin A
Prostaglandins; 1992 Apr; 43(4):351-60. PubMed ID: 1535164
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin H2-thromboxane A2 and renal functions in the Lyon hypertensive rat.
Liu KL; Benzoni D; Sassard J
Am J Physiol; 1994 May; 266(5 Pt 2):R1530-6. PubMed ID: 8203630
[TBL] [Abstract][Full Text] [Related]
13. Mesangial cell immune injury: effects of thromboxane receptor antagonism.
Bresnahan BA; Roman RJ; Bagchus WM; Lianos EA
J Am Soc Nephrol; 1991 Feb; 1(8):1041-7. PubMed ID: 1832980
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock.
Patel JP; Beck LD; Briglia FA; Hock CE
Crit Care Med; 1995 Feb; 23(2):231-7. PubMed ID: 7867347
[TBL] [Abstract][Full Text] [Related]
15. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats.
Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ
Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827
[TBL] [Abstract][Full Text] [Related]
16. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.
Fogo A; Hellings SE; Inagami T; Kon V
Kidney Int; 1992 Sep; 42(3):770-4. PubMed ID: 1405355
[TBL] [Abstract][Full Text] [Related]
18. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
Takahashi K; Nammour TM; Fukunaga M; Ebert J; Morrow JD; Roberts LJ; Hoover RL; Badr KF
J Clin Invest; 1992 Jul; 90(1):136-41. PubMed ID: 1386085
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro.
Piper PJ; Samhoun MN
Br J Pharmacol; 1982 Oct; 77(2):267-75. PubMed ID: 6291685
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
Yoo J; Schlondorff D; Neugarten J
J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
